Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Bone Health

Université Laval

$100,000.00

Identification of rare genetic variants in Paget's disease of bone

EF 2010-11

Résumé
Paget's disease of bone (PDB) is the second most frequent bone disorder after osteoporosis, affecting approximately three percent of people over 55 years of age. Disabling complications of PDB, such as bone deformity, bone pain and fractures, occur in about 30% of PDB patients. PDB is caused by over-activity of osteoclasts, bone cells that remove bone tissue. A genetic component of this disease is well-known and a mutation in a gene linked to PDB has been identified in the French-Canadian population. A second genetic component is currently being investigated in our laboratory from genetic material from several French-Canadian families affected by PDB, but who do not already have the currently-known mutation. However, there is some evidence in the French-Canadian population that both genetic regions cited above may not completely account for disease susceptibility in all PDB individuals and families, suggesting the presence of at least one other genetic factor of PDB susceptibility. In this study, we will search for rare genetic variations in our cohort of patients affected by PDB and in healthy controls from the French-Canadian population. The French-Canadian population is a historically-young population that was established by a very small number of individuals from a larger population. This type of population is particularly well-suited for identifying rare genetic variations. By identifying novel genetic factors of susceptibility in PDB, we will better understand the molecular mechanisms of PDB and other similar bone diseases, such as osteoporosis and bone metastases, which are increasingly prevalent in our aging Canadian population. A better understanding of bone diseases will allow for the development of new, better treatments designed to regulate bone resorption. Preventing and appropriately treating bone diseases would have a major impact on public health by decreasing the direct and indirect costs associated with chronic bone diseases.
Programme
Catalyst Grant: Bone Health
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
207671
Name
Michou Laetitia N
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Catalyst Grant: Bone Health
Projecttitle
Identification of rare genetic variants in Paget's disease of bone
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Bone Health
Keyworddelim
Allele Frequency; Candidate Gene; Common Genetic Variants; Founder Effect; Genetic Association Study; Metabolic Bone Disease; Paget'S Disease Of Bone; Rare Genetic Variants; Resequencing; Segregation Analysis
Abstract
Paget's disease of bone (PDB) is the second most frequent bone disorder after osteoporosis, affecting approximately three percent of people over 55 years of age. Disabling complications of PDB, such as bone deformity, bone pain and fractures, occur in about 30% of PDB patients. PDB is caused by over-activity of osteoclasts, bone cells that remove bone tissue. A genetic component of this disease is well-known and a mutation in a gene linked to PDB has been identified in the French-Canadian population. A second genetic component is currently being investigated in our laboratory from genetic material from several French-Canadian families affected by PDB, but who do not already have the currently-known mutation. However, there is some evidence in the French-Canadian population that both genetic regions cited above may not completely account for disease susceptibility in all PDB individuals and families, suggesting the presence of at least one other genetic factor of PDB susceptibility. In this study, we will search for rare genetic variations in our cohort of patients affected by PDB and in healthy controls from the French-Canadian population. The French-Canadian population is a historically-young population that was established by a very small number of individuals from a larger population. This type of population is particularly well-suited for identifying rare genetic variations. By identifying novel genetic factors of susceptibility in PDB, we will better understand the molecular mechanisms of PDB and other similar bone diseases, such as osteoporosis and bone metastases, which are increasingly prevalent in our aging Canadian population. A better understanding of bone diseases will allow for the development of new, better treatments designed to regulate bone resorption. Preventing and appropriately treating bone diseases would have a major impact on public health by decreasing the direct and indirect costs associated with chronic bone diseases.
Competitiondate
201006
Approvedterm2
1 yr 0 mth
Pinamesdelim
Michou, Laetitia N
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $100,000~ $0~